| JSTCT2023 President Yoshiki Akatsuka (Designated professor, Department of Immunology, Nagoya University Graduate School of Medicine) |
 |
|---|
On behalf of the Japan Society for Transplantation and Cell Therapy (JTCT), it is my great pleasure and honor to host the 45th JSTCT Annual Meeting on February 10th-12th, 2023, at the Nagoya Congress Center, Nagoya, Japan. This is the 7th congress in Nagoya since the first congress back in 1978. The theme for the congress was set as "Let's get excited about new technologies in transplantation and cell therapy." From the dawn of bone marrow transplantation until now, there have been a lot of critical breakthroughs such as the introduction of cyclosporin, the development of various donor sources, non-myeloablative regimens, post-transplant cyclophosphamide, mesenchymal stem cell, and chimeric antigen receptor T-cells. Recently, the advent of single-cell analysis by taking advantage of single-cell sequencing and AI-related multidimensional analyses made it possible to trace the individual cell fate in various situations at a much higher level than ever. We are witnessing such an exciting moment now. We plan a symposium where attendees will be able to experience the transitional moment to the next stage where such technologies will solve the mechanism of therapeutic effect and adverse events following transplantation and cell therapy. We will invite frontline researchers from both home and abroad for most of the symposium and plan a sufficient timeframe for a hot panel discussion. Furthermore, an interactive discussion among speakers and attendees will be provided for the Pro/Con sessions and workshops. As online lectures have reduced the limitation of time difference and distance worldwide, opportunities to discuss with more foreign speakers will be organized for plans for co-medicals using simultaneous interpreting. We, members of the program committee and congress office, sincerely expect as many attendees as possible to get excited, learn, and be satisfied through the programs mentioned above.